Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Sharp

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
The International Journal of Neuropsychopharmacology|July 8, 2011
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxineFlorence Serres, Mark J Millan, Trevor Sharp
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
Psychopharmacology|January 28, 2004
Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brainMarisa Le Masurier, Philip J Cowen, Trevor Sharp
Trends in Pharmacological Sciences|November 13, 2007
Important messages in the 'post': recent discoveries in 5-HT neurone feedback controlTrevor Sharp, Laura Boothman, Josie Raley, et al.
Neuropharmacology|January 26, 2006
Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysisLaura J Boothman, Stephen N Mitchell, Trevor Sharp
Neuroscience Letters|April 13, 2010
Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levelsCecilie Löe Licht, Gitte Moos Knudsen, Trevor Sharp
Neuropharmacology|June 20, 2003
In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptorsMihály Hajós, Sarah E Gartside, Viktor Varga, et al.
Journal of Psychopharmacology (Oxford, England)|October 11, 2013
Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent mannerMarisa Le Masurier, Tyra Zetterström, Philip Cowen, et al.
Neuropharmacology|January 22, 2011
Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?Sonny K H Tan, Henrike Hartung, Trevor Sharp, et al.
The European Journal of Neuroscience|September 14, 2016
High-frequency stimulation of the subthalamic nucleus modulates neuronal activity in the lateral habenula nucleusHenrike Hartung, Sonny K H Tan, Yasin Temel, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
The International Journal of Neuropsychopharmacology|July 8, 2011
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxineFlorence Serres, Mark J Millan, Trevor Sharp
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
Psychopharmacology|January 28, 2004
Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brainMarisa Le Masurier, Philip J Cowen, Trevor Sharp
Trends in Pharmacological Sciences|November 13, 2007
Important messages in the 'post': recent discoveries in 5-HT neurone feedback controlTrevor Sharp, Laura Boothman, Josie Raley, et al.
Neuropharmacology|January 26, 2006
Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysisLaura J Boothman, Stephen N Mitchell, Trevor Sharp
Neuroscience Letters|April 13, 2010
Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levelsCecilie Löe Licht, Gitte Moos Knudsen, Trevor Sharp
Neuropharmacology|June 20, 2003
In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptorsMihály Hajós, Sarah E Gartside, Viktor Varga, et al.
Journal of Psychopharmacology (Oxford, England)|October 11, 2013
Tyrosine-free amino acid mixtures reduce physiologically-evoked release of dopamine in a selective and activity-dependent mannerMarisa Le Masurier, Tyra Zetterström, Philip Cowen, et al.
Neuropharmacology|January 22, 2011
Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?Sonny K H Tan, Henrike Hartung, Trevor Sharp, et al.
The European Journal of Neuroscience|September 14, 2016
High-frequency stimulation of the subthalamic nucleus modulates neuronal activity in the lateral habenula nucleusHenrike Hartung, Sonny K H Tan, Yasin Temel, et al.
Pageof 10